1,300
Views
13
CrossRef citations to date
0
Altmetric
Clinical Study

Effect of Nonsurgical Periodontal Treatment on C-Reactive Protein Levels in Maintenance Hemodialysis Patients

, , &
Pages 711-717 | Received 14 Dec 2012, Accepted 15 Feb 2013, Published online: 28 Mar 2013

REFERENCES

  • Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820.
  • D’Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res. 2004;39:236–241. doi:10.1111/j.1600-0765.2004.00731.x
  • Kshirsagar AV, Kl M, Elter JR, Beck JD, Offenbacher S, Falk RJ. Periodontal disease is associated with renal insufficiency in the atherosclerosis risk in communities (ARIC). Am J Kidney Dis. 2005;45(4):650–657.
  • Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A. Effect of periodontal treatment on serum C-reactive protein levels: A systematic review and meta-analysis. J Periodontol. 2006;77(10):1635–1642.
  • Gjermo P. 1998. Epidemiology of periodontal diseases in Europe. J Parodontol d’Implantol Orale. 17:111–121.
  • D’Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J. 2006;151:977–984.
  • Craig RG. Special Review in Periodontal Medicine Interactions between chronic renal disease and periodontal disease. Oral Dis. 2008;14:1–7.
  • Crawford PW, Lerma EV. Treatment options for end stage renal disease. Prim Care. 2008;35:407–432.
  • US. Renal Data System: USRDS. Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2006.
  • Kshirsagar AV, Craig RG, Beck JD, Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol. 2007;2(2):239–244 [Epub January 24, 2007].
  • Bayraktar G, Kurtulus I, Kazancioglu R, et al. Evaluation of periodontal parameters in patients undergoing peritoneal dialysis or hemodialysis. Oral Dis. 2008;14:185–189.
  • Litlle JW, Falace DA, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. 7th ed. St. Louis, MO: Mosby; 2008:180 p.
  • Linden GJ, McClean K, Young I, Evans A, Kee F. Persistently raised C-reactive protein levels are associated with advanced periodontal disease. J Clin Periodontol. 2008;35:741–747.
  • Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–1812.
  • Blake GJ, Ridker PM. 2002. Inflammatory bio-markers and cardiovascular risk prediction. J Int Med. 252:283–294.
  • RidkerP M, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-dentistry lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565.
  • Lu Q, Jin L. 2010. Human gingiva is another site of C-reactive protein formation. J Clin Periodontol. 37:789–796.
  • Craig RG, Spittle MA, Levin NW. Importance of periodontal disease in the kidney patient. Blood Purif. 2002;20:113–119.
  • Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 2001;21(Suppl 3):157–162.
  • Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14): 1387–1397.
  • Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequency colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1383–1392.
  • Söder PO, Söder B, Nowak J, Jogestrand T. 2005. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke. 36:1195–1200.
  • Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001;72(9):1221–1227.
  • Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT. Periodontal disease and risk of cerebrovascular disease: The first national health and nutrition examination survey and its follow-up study. Arch Intern Med. 2000;160(18):2749–2755.
  • Hilana Paula Carillo Artese. Celso Oliveira de Sousa. Ronir Raggio Luiz. Carmelo Sansone. Maria Cynésia Medeiros de Barros Torres. Braz Oral Res. 2010;24(4):449–454.
  • Rogowski O, Vered Y, Shapira I, Hirsh M, Zakut V, Berliner S. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta. 2005;358(1–2):151–158.
  • Helal I, Zerelli L, Krid M, Comparison of C-reactive protein and high-sensitivity C-reactive protein levels in patients on hemodialysis. Saudi J Kidney Dis Transpl. 2012;23(3): 477–483.
  • World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. J Am Med Assoc. 1997;277(11):925–926.
  • Armitage GC. Development of a classification system for periodontal diseases and conditions. Bon Perim/onto. 1999;4:1.
  • D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005;84(3):269–273.
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143. doi:10.1161/hc0902.104353.
  • Bl P, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820. doi:10.1016/S0140-6736(05)67728-8
  • Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH. Impact of elevated C-reactive protein levels on erythropoiesis-stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Nephrol Dial Transplant. 2009;24(3):919–925 [Epub October 7, 2008].
  • Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. Antibodies to periodontal organisms are associated with decreased kidney function: the dental atherosclerosis risk in communities study. Blood Purif. 2007;25:125–132. doi:10.1159/000096411
  • D’Aiuto F, Parkar M, Andreou G, Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004;83(2):156–160.
  • Paraskevas S, Huizinga JD, Loss BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35:277–279. doi:10.1111/j.1600-051X.2007.01173.x
  • Vilela EM, Bastos JA, Fernandes N, Ferreira AP, Chaoubah A, Bastos MG. Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo). 2011;66(4):657–662.
  • Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis. 2006;47(5):815–822.
  • Siribamrungwong M, Puangpanngam K. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients. Ren Fail. 2012;34(2):171–175 [Epub January 9, 2012].
  • Freitas CO, Gomes-Filho IS, Naves RC, Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci. 2012;20(1):1–8.
  • Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 2002;9:425–432.
  • Yamazaki K, Honda T, Oda T, Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res. 2005;40(1):53–58.
  • Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol. 2003;30:334–340.
  • Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454.
  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97(5):425–428.
  • Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97(20):2007–2011.
  • Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease in acute phase proteins: a populations-based study. Eur Heart J. 1999;20:954–959.
  • Lagrand WK, Visser CA, Hermens WT, C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100(1):96–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.